This is an old revision of this page, as edited by DMacks (talk | contribs) at 23:55, 23 June 2020 (Remove malformatted |molecular_weight= when infobox can autocalculate it, per Wikipedia talk:WikiProject Pharmacology#Molecular weights in drugboxes (via WP:JWB)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
 | This article does not cite any sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Trimethyldiphenylpropylamine" – news · newspapers · books · scholar · JSTOR (February 2010) (Learn how and when to remove this message) |
 | |
| Clinical data | |
|---|---|
| ATC code | |
| Identifiers | |
| |
| PubChem CID | |
| ChemSpider | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C18H23N |
| Molar mass | 253.389 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Trimethyldiphenylpropylamine (N,N,1-Trimethyl-3,3-diphenylpropylamine) is a drug used for functional gastrointestinal disorders. Its tradename is Recipavrin.
See also: Emepronium
Drugs for functional gastrointestinal disorders (A03) | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Drugs for functional bowel disorders |
| ||||||||||||
| Belladonna and derivatives (antimuscarinics) |
| ||||||||||||
| Propulsives | |||||||||||||
 | This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it. |
